Sonnet BioTherapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • CEO Corner
  • Technology
    • Overview
    • Platform
    • Publications
  • Pipeline
    • Overview
    • SON-1010
    • SON-1210
    • SON-080
    • Clinical Trials
  • Partnering
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact

Financial Results

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Governance Documents
  • Financial Info

  • Overview
  • Financial Results
  • Income Statement
  • Balance Sheet
  • Cash Flow

2025

Q1 2025

Quarter Ended Dec 31, 2024
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2024

FY 2024

Fiscal Year Ended Sep 30, 2024
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2024

Quarter Ended Jun 30, 2024
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2024

Quarter Ended Mar 31, 2024
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2024

Quarter Ended Dec 31, 2023
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2023

FY 2023

Fiscal Year Ended Sep 30, 2023
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2023

Quarter Ended Jun 30, 2023
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2023

Quarter Ended Mar 31, 2023
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2023

Quarter Ended Dec 31, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2022

FY 2022

Fiscal Year Ended Sep 30, 2022
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2022

Quarter Ended Jun 30, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2022

Quarter Ended Mar 31, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2022

Quarter Ended Dec 31, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2021

FY 2021

Fiscal Year Ended Sep 30, 2021
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2021

Quarter Ended Jun 30, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2021

Quarter Ended Mar 31, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2021

Quarter Ended Dec 31, 2020
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2020

FY 2020

Fiscal Year Ended Sep 30, 2020
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2020

Quarter Ended Jun 30, 2020
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
© 2025 Sonnet BioTherapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap